Dow Up 0.11% Nasdaq Up 0.50%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
1.41 Up 0.03(2.17%) Aug 29, 4:00PM EDT
Prev Close:1.38
Open:1.38
Bid:1.40 x 10800
Ask:1.41 x 16300
1y Target Est:5.63
Beta:2.25
Next Earnings Date:N/A
Day's Range:1.37 - 1.41
52wk Range:1.26 - 3.93
Volume:245,132
Avg Vol (3m):417,191
Market Cap:112.15M
P/E (ttm):N/A
EPS (ttm):-0.42
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTX

Comparison

Symbol% ChgMkt Cap
CYTXUp 2.17%112.15M
ASTM 0.00%30.96M
BAXUp 0.09%40.61B
OSIRUp 0.99%490.28M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.34
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.44
Quarterly EPS Est (Sep-14) :-0.10
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a cell therapy company, develops cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback